Yaohua Wu

Yaohua Wu


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2021 in Free Radical Biology and Medicine
Verified
Journal Article
Open access
CWChaoqun Wang
Chaoqun Wang
LDLiqian Dong
Liqian Dong
XLXiaozhuang Li
Xiaozhuang Li
YLYao Li
Yao Li
BZBao Zhang
Bao Zhang
YMYong Ma
Yong Ma
Targeting energy metabolism holds the potential to effectively treat a variety of malignant diseases, and peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC1α) is a key regulator of energy metabolism. However, PGC1α's role in cancer, especially in hepatocellular carcinoma (HCC) remains largely unknown. In the present study, we reported that PGC1α was significantly downregulated in HCC cell lines and specimens. Moreover, reduced expression of PGC1α in tumor cells was correlated with poor prognosis. PGC1α overexpression substantially inhibited cell proliferation and induced apoptosis in vitro and in vivo. On the contrary, the knockdown of PGC1α produced the opposite effect. The mechanism was at least partially due to the upregulation of mitochondrial pyruvate carrier 1 (MPC1) caused by PGC1α, which promoted mitochondrial biogenesis by binding to nuclear respiratory factor 1 (NRF1). Consequently, the production of cellular reactive oxygen species (ROS) caused by mitochondrial oxidation was elevated above a critical threshold for survival. Furthermore, we found that PGC1α could enhance the antitumor activity of sorafenib and doxorubicin in HCC through ROS accumulation-mediated cell death. These results indicate that PGC1α/NRF1-MPC1 axis is involved in HCC progression and could be a promising target for HCC treatment.

18 July 2022 in Oncogenesis
Verified
Journal Article
Open access
PDF file
SLShounan Lu
Shounan Lu
SKShanjia Ke
Shanjia Ke
CWChaoqun Wang
Chaoqun Wang
YXYanan Xu
Yanan Xu
ZLZihao Li
Zihao Li
YMYong Ma
Yong Ma
Nicotinamide N-methyltransferase (NNMT), a member of the N-methyltransferase family, plays an important role in tumorigenesis. However, its expression and biological functions in intrahepatic cholangiocarcinoma (iCCA) remain to be established. In our study, we identified NNMT as an oncogene in iCCA and provided mechanistic insights into the roles of NNMT in iCCA progression. High NNMT expression in iCCA tissues was identified using western blotting and immunohistochemistry (IHC). We identified a significantly higher NNMT expression level in human iCCA tissues than that in adjacent normal tissues. Increased NNMT expression promoted iCCA cell proliferation and metastasis in vitro and in vivo. Mechanistically, NNMT inhibited the level of histone methylation in iCCA cells by consuming the methyl donor S-adenosyl methionine (SAM), thereby promoting the expression of epidermal growth factor receptor (EGFR). EGFR may activate the aerobic glycolysis pathway in iCCA cells by activating the STAT3 signaling pathway. In conclusion, we identified NNMT as an oncogene in iCCA and provided mechanistic insights into the roles of NNMT in iCCA progression.

4 May 2023 in Oncogene
Verified
Journal Article
Closed access
PDF file
ZFZhigang Feng
Zhigang Feng
SKShanjia Ke
Shanjia Ke
CWChaoqun Wang
Chaoqun Wang
SLShounan Lu
Shounan Lu
YXYanan Xu
Yanan Xu
YMYong Ma
Yong Ma

1 January 2021 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
CWChaoqun Wang
Chaoqun Wang
ZLZihao Li
Zihao Li
BZBaolei Zhao
Baolei Zhao
YWYaohua Wu
Yaohua Wu
YFYao Fu
Yao Fu
YMYong Ma
Yong Ma
Peroxisome proliferator‐activated receptors (PPARs) α and γ have been shown to be protective in hepatic ischemia/reperfusion (I/R) injury. However, the precise role of PPARγ coactivator‐1α (PGC‐1α), which can coactivate both of these receptors, in hepatic I/R injury, remains largely unknown. This study was designed to test our hypothesis that PGC‐1α is protective during hepatic I/R injury in vitro and in vivo. Our results show that endogenous PGC‐1α is basally expressed in normal livers and is moderately increased by I/R. Ectopic PGC‐1α protects against hepatic I/R and hepatocyte anoxia/reoxygenation (A/R) injuries, whereas knockdown of endogenous PGC‐1α aggravates such injuries, as evidenced by assessment of the levels of serum aminotransferases and inflammatory cytokines, necrosis, apoptosis, cell viability, and histological examination. The EMSA assay shows that the activation of PPARα and PPARγ is increased or decreased by the overexpression or knockdown of PGC‐1α, respectively, during hepatic I/R and hepatocyte A/R injuries. In addition, the administration of specific antagonists of either PPARα (MK886) or PPARγ (GW9662) can effectively decrease the protective effect of PGC‐1α against hepatic I/R and hepatocyte A/R injuries. We also demonstrate an important regulatory role of PGC‐1α in reactive oxygen species (ROS) metabolism during hepatic I/R, which is correlated with the induction of ROS‐detoxifying enzymes and is also dependent on the activations of PPARα and PPARγ. These data demonstrate that PGC‐1α protects against hepatic I/R injury, mainly by regulating the activation of PPARα and PPARγ. Thus, PGC‐1α may be a promising therapeutic target for the protection of the liver against I/R injury.

3 June 2024 in Experimental & Molecular Medicine
Verified
Journal Article
Open access
PDF file
SKShanjia Ke
Shanjia Ke
SLShounan Lu
Shounan Lu
YXYanan Xu
Yanan Xu
MBMiaoyu Bai
Miaoyu Bai
HYHongjun Yu
Hongjun Yu
YMYong Ma
Yong Ma
Hepatocellular carcinoma (HCC) is one of the most common fatal cancers worldwide, and the identification of novel treatment targets and prognostic biomarkers is urgently needed because of its unsatisfactory prognosis. Regulator of G-protein signaling 19 (RGS19) is a multifunctional protein that regulates the progression of various cancers. However, the specific function of RGS19 in HCC remains unclear. The expression of RGS19 was determined in clinical HCC samples. Functional and molecular biology experiments involving RGS19 were performed to explore the potential mechanisms of RGS19 in HCC. The results showed that the expression of RGS19 is upregulated in HCC tissues and is significantly associated with poor prognosis in HCC patients. RGS19 promotes the proliferation and metastasis of HCC cells in vitro and in vivo. Mechanistically, RGS19, via its RGS domain, stabilizes the MYH9 protein by directly inhibiting the interaction of MYH9 with STUB1, which has been identified as an E3 ligase of MYH9. Moreover, RGS19 activates β-catenin/c-Myc signaling via MYH9, and RGS19 is also a transcriptional target gene of c-Myc. A positive feedback loop formed by RGS19, MYH9, and the β-catenin/c-Myc axis was found in HCC. In conclusion, our research revealed that competition between RGS19 and STUB1 is a critical mechanism of MYH9 regulation and that the RGS19/MYH9/β-catenin/c-Myc feedback loop may represent a promising strategy for HCC therapy.

23 September 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
BQBaolin Qian
Baolin Qian
QLQi Liu
Qi Liu
CWChaoqun Wang
Chaoqun Wang
SLShounan Lu
Shounan Lu
SKShanjia Ke
Shanjia Ke
YMYong Ma
Yong Ma
Pancreatic cancer is one of the tumors with the worst prognosis, causing serious harm to human health. The RNA network and immune response play an important role in tumor progression. While a systematic RNA network linked to the tumor immune response remains to be further explored in pancreatic cancer. Based on The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases, the MIR600HG/hsa-miR-342-3p/ANLN network was determined. WB and IHC were used to confirm the high expression of ANLN in pancreatic cancer. The prognostic model based on the RNA network could effectively predict the survival prognosis of patients. The analysis of immune infiltration showed that the MIR600HG/hsa-miR-342-3p/ANLN network altered the level of infiltration of T helper 2 (Th2) and effector memory T (Tem) cells. Furthermore, we found that the chemokines chemokine ligand (CCL) 5 and CCL14 may play a key role in immune cell infiltration mediated by the RNA network. In conclusion, this study constructed a prognostic model based on the MIR600HG/hsa-miR-342-3p/ANLN network and found that it may function in tumor immunity.